PODCAST

Urology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Advancements in GU Cancers: Key Data from AUA 2024

Urology ·

2024/07/18

Host: Jason Hafron, MD Guest: Carissa Chu. MD Despite treatment advances in genitourinary cancers, most patients will develop relapsed disease. Thus, new treatment approaches are needed, as well as improved methods to identify patients who will derive the optimal benefit from established and emerging therapies. Real-world data provide crucial insight into practice patterns and response rates, ultimately guiding individualization of treatment selection. In this activity, expert

00:00:00

What Is the Current State of Disparities in Prostate...

Urology ·

2023/09/29

Host: Alicia K. Morgans, MD, MPH Host: Kelvin A. Moses, MD, PhD, FACS This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information

00:00:00

Expert Panel: Selecting Treatment in mHSPC: Which...

Urology ·

2023/09/29

Host: Kelvin A. Moses, MD, PhD, FACS Host: Alicia K. Morgans, MD, MPH This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information

00:00:00

Expert Panel: How Does ADT Intensification for mHSPC...

Urology ·

2023/09/29

00:00:00

Expert Panel: How Can We Integrate Patient Preference...

Urology ·

2023/09/29

00:00:00

How Nurses and Advanced Practice Clinicians Can Help...

Urology ·

2023/09/29

Host: Stacy Walker, NP This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation of androgen

00:00:00

What Is the Pharmacist’s Role in Managing mHSPC...

Urology ·

2023/09/29

Host: Lisa Holle, PharmD, BCOP, FHOPA, FISOPP This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective

00:00:00

Choosing Between Doublets and Triplets in mHSPC: What...

Urology ·

2023/09/29

Host: Alicia K. Morgans, MD, MPHThis program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation of

00:00:00

What Can I Do to Improve Care of Prostate Cancer...

Urology ·

2023/09/29

Host: Kelvin A. Moses, MD, PhD, FACS This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation

00:00:00

Expert Panel: What Is the Future of Early...

Urology ·

2023/08/18

Host: Rana McKay, MD Host: Neeraj Agarwal, MD, FASCO Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and

00:00:00

What Is the Future of Neoadjuvant ARI Intensification...

Urology ·

2023/08/18

Host: Rana McKay, MD Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and the benefit of other second-generation

00:00:00

Should We Make Active Surveillance More Active for...

Urology ·

2023/08/18

Host: Neeraj Agarwal, MD, FASCO Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and the benefit of other

00:00:00

Case Study: How Do We Optimize Treatment Adherence...

Urology ·

2023/08/18

00:00:00

Can ARIs Be Combined with Radiation Therapy in...

Urology ·

2023/08/18

00:00:00

How Do We Identify Patients with Localized Prostate...

Urology ·

2023/08/18

00:00:00

How Are ARIs Being Used to Intensify Therapy for...

Urology ·

2023/08/18

00:00:00

Optimizing the Use of Immunotherapy in the First-line...

Urology ·

2023/07/19

Guest: Petros Grivas, MD, PhD Guest: Thomas Powles, MD, PhD Survival for patients with metastatic urothelial cancer has increased with the approval of immune therapy, antibody-drug conjugates, and targeted agents. In the maintenance setting, avelumab has become the global standard of care. Do you know how to evaluate and effectively implement immune therapy in the maintenance setting in your practice?

00:00:00

Understanding the Biological and Clinical Rationale...

Urology ·

2023/06/29

Host: Neeraj Agarwal, MD, FASCO Prostate cancer is a disease characterized by high genomic instability. Prostate cancers with deleterious aberrations in DNA damage repair (DDR) genes, including homologous recombination repair (HRR), such as mutations in BRCA1/2 and ATM, are associated with response to poly(adenosine diphosphate–ribose) polymerase (PARP) inhibition. The US Food and Drug Administration (FDA) has approved PARP inhibitors as monotherapy for the treatment of previously

00:00:00

Recent Progress in Nonmetastatic Castration-Resistant...

Urology ·

2023/03/03

Host: Daniel J. George, MD Host: Fred Saad, MD, FRCS The ASCO Genitourinary (ASCO GU) and the Annual ASCO meetings are the leading educational and scientific events for oncologists, urologists, and the cancer team, providing the latest clinical and scientific data from clinical trials and basic and translational research in GU cancer. Thousands of abstracts summarizing state-of-the-art treatment modalities and novel therapies for patients with Prostate Cancer will be presented and

00:00:00

Data Updates in the Treatment of Hormone Sensitive...

Urology ·

2023/03/03

24 results

Urology

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事